Refine
Has Fulltext
- yes (124) (remove)
Is part of the Bibliography
- yes (124)
Year of publication
- 2021 (124) (remove)
Document Type
- Doctoral Thesis (123)
- Journal article (1)
Keywords
- Melanom (3)
- Angst (2)
- Angststörung (2)
- Arteriosklerose (2)
- Chlamydia trachomatis (2)
- Chromatin (2)
- DNA repair (2)
- Entzündung (2)
- Fluoreszenzmikroskopie (2)
- Fuchsbandwurm (2)
- Furcht (2)
- Furchtkonditionierung (2)
- G-Protein gekoppelte Rezeptoren (2)
- GPCR (2)
- Genetik (2)
- HUWE1 (2)
- Induzierte pluripotente Stammzelle (2)
- MAP-Kinase (2)
- MYC (2)
- MYCN (2)
- Maus (2)
- Mausmodell (2)
- Megakaryozyt (2)
- Multiple Sklerose (2)
- Multiples Myelom (2)
- Neisseria meningitidis (2)
- Neuroblastom (2)
- Neurodegeneration (2)
- Plasmozytom (2)
- Resistenz (2)
- Serotonin (2)
- Sphingolipide (2)
- Stammzelle (2)
- Thrombozyt (2)
- Tissue Engineering (2)
- Transcription (2)
- TrkB (2)
- Ubiquitin (2)
- Zellskelett (2)
- cAMP (2)
- cell wall (2)
- host-pathogen interaction (2)
- neuroblastoma (2)
- neuropathy (2)
- regulation (2)
- 177Lu-OPS201 (1)
- 3D models (1)
- 3D tissue model (1)
- 3D-Gewebemodell (1)
- 5`-UTR (1)
- 68Ga-OPS202 (1)
- 7T (1)
- ACC (1)
- ADGRL3 (1)
- ADHD (1)
- AI (1)
- ATF5 (1)
- ATGL (1)
- Acetylation (1)
- Acute myeloid leukemia (AML) (1)
- Adhesion GPCR (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adrenalin (1)
- Adrenokortikales Karzinom (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Adventitia (1)
- Agarose (1)
- Aiolos (1)
- Airway epithelia (1)
- Alzheimerkrankheit (1)
- Angstverhalten (1)
- Anthropocene (1)
- Anti-CD52-Antikörper (1)
- Antibody (1)
- Antigen CD44 (1)
- Antioxidantien (1)
- Aortenaneurysma (1)
- Arbeitsteilung (1)
- Arid biomes (1)
- Arrestine (1)
- Artesunate (1)
- Arzneimittel (1)
- Arzneimitteldesign (1)
- Arzneimittelzulassung (1)
- Aspergillus fumigatus (1)
- Atherosklerose (1)
- Aufmerksamkeit (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aurora-A (1)
- Aussterbedynamik (1)
- Autoantikörper (1)
- B cells (1)
- BDNF (1)
- BRCA1 (1)
- BTB domain (1)
- Bacillus subtilis (1)
- Bahnung (1)
- Bakterienzellwand (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Bildanalyse (1)
- Biodistribution (1)
- Biogenese (1)
- Biolayerinterferometrie (1)
- Biologie (1)
- Bioluminescence resonance energy transfer (1)
- Biomarker (1)
- Biomaterial (1)
- Bioprinting (1)
- Bioreactor (1)
- Bioreaktor (1)
- Bitopic Ligands (1)
- Bitopische Liganden (1)
- Blickbewegung (1)
- Blickinteraktion (1)
- Blut-Rückenmarkschranke (1)
- Bordetella (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- CCR4 (1)
- CD28 (1)
- CD28-SA (1)
- CD44 (1)
- CD84 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CIDP (1)
- CMT1A (1)
- Caenorhabditis elegans (1)
- Camponotus rufipes (1)
- Candida albicans (1)
- Cardiac (1)
- Cardiomyocyte (1)
- Cartilage (1)
- Cartilage Tissue Engineering (1)
- Cataglyphis (1)
- Ccr4-Not (1)
- Celecoxib (1)
- Cell-Assisted Lipotransfer (1)
- Ceramide (1)
- Charcot-Marie-Tooth 1A (1)
- Chemotaxis (1)
- Chimeric antigen receptor (CAR) (1)
- Chimpanzee (1)
- Chronobiologie (1)
- Ciliary neurotrophic factor (1)
- Click-Chemie (1)
- Co-Kultur (1)
- Co-culture system (1)
- Cochlear-Implantat (1)
- Comoé National Park (1)
- Complement system (1)
- Conditioning (1)
- Cortico-striatal projection neurons (1)
- Craniosynostosis (1)
- Cushing-Syndrom (1)
- Cuticular transpiration (1)
- Cuticular waxes (1)
- Cyclo-AMP (1)
- Cystein (1)
- Cytoskeleton (1)
- DC (1)
- DNS-Reparatur (1)
- DOT1 (1)
- DTI (1)
- Danio rerio (1)
- Decapping (1)
- Deeplearning (1)
- Deletion (1)
- Dendritische Zelle (1)
- Depletion (1)
- Depression (1)
- Diabetes mellitus (1)
- Differential scanning calorimetry (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Drosophila (1)
- Drug resistance (1)
- Duplikation (1)
- E2 (1)
- ECAP (1)
- ECG-gated PET (1)
- EEG (1)
- Early-Life Stress (1)
- Echinococcus multilocularis (1)
- Effect anticipation (1)
- Effektantizipation (1)
- Einzelmolekülmikroskopie (1)
- Elektrostimulation (1)
- Entwicklung (1)
- Eosinophiler Granulozyt (1)
- Epigenetic (1)
- Epigenetik (1)
- Evolution (1)
- Expansion microscopy (1)
- Expansionsmikroskopie (1)
- Experimentelle autoimmune Enzephalomyelitis (1)
- Exposition (1)
- Expositionslernen (1)
- Expositionstherapie (1)
- Extinktion (1)
- Extracellular Vesicles (1)
- FLT3 inhibitor (1)
- FMS-like tyrosine kinase 3 (FLT3) (1)
- FRET (1)
- FT-IR-Spektroskopie (1)
- Ferroptosis (1)
- Fertilization in angiosperm (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Fitness (1)
- Flavonoide (1)
- Flippase (1)
- Flow (1)
- Fluconazol (1)
- Fluconazole (1)
- Fluorescence correlation spectroscopy (1)
- Fluss (1)
- Folliculin (1)
- Foxo1 (1)
- Fragmentscreening (1)
- Functional analyses (1)
- Furagieraktivität (1)
- Furchtgeneralisierung (1)
- Förster Resonanz Energie Transfer (1)
- G glycoprotein (1)
- G-Protein gekoppelter Rezeptor (1)
- G-protein-coupled receptors (1)
- GMP (1)
- Gaze interaction (1)
- Gefäßwand (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gehirn (1)
- Gen BRCA 1 (1)
- Genetics (1)
- Genexpression (1)
- Genotoxicity (1)
- Genotoxizität (1)
- Genregulation (1)
- Gewebekultur (1)
- Glia (1)
- Glioblastom (1)
- Gliom (1)
- Glucose Starvation (1)
- Glutathion (1)
- Glycinrezeptor (1)
- Glycophyten (1)
- Glykomodifizierung (1)
- Glykosylierung (1)
- Gonococcal invasion (1)
- GvHD (1)
- H2A.Z (1)
- HECTD1 (1)
- HFpEF (1)
- Halophyten (1)
- Halophytes (1)
- Heart (1)
- Heart development (1)
- Heat stress (1)
- Helicobacter pylori (1)
- Herz (1)
- Herzinfarkt (1)
- Heubacillus (1)
- High-thropughput screening (1)
- Hippo pathway (1)
- Hippocampus (1)
- Hirnhaut (1)
- Histon-Methyltransferase (1)
- Histonacetyltransferase (1)
- Histone (1)
- Histone Acetylation (1)
- Histone modification (1)
- Histone variant (1)
- Hochauflösungsmikroskopie (1)
- Hochdurchsatz-Screening (1)
- Hornhaut (1)
- Huh6 (1)
- Human Transcriptome (1)
- Human-pathogenic (1)
- Hyaliner Knorpel (1)
- Hyaluronsäure (1)
- Hydrogel (1)
- Hypoxia (1)
- Hypoxie (1)
- Hämophilie A (1)
- Höhenangst (1)
- IKZF1 (1)
- IKZF3 (1)
- IRAK2 (1)
- Ideomotor gaze control (1)
- Ideomotorik (1)
- Ideomotorische Blickkontrolle (1)
- Ikaros (1)
- Immunological synapse (1)
- Immunozyt (1)
- Immunsystem (1)
- Immunzellrekrutierung (1)
- In-vitro-Kultur (1)
- Individualisierte Medizin (1)
- Infektion (1)
- Inflammation (1)
- Inhibitor (1)
- Insektenstaaten (1)
- Insulin (1)
- Interleukin (1)
- Interleukin 5 (1)
- Interleukin-4 Antagonist (1)
- Intracellular bacteria (1)
- Intrazelluläre Bakterien (1)
- Ischemia (1)
- Karotis-Intima-Media-Dicke (1)
- Kleine Proteine (1)
- Kleinkern (1)
- Knorpel (1)
- Kofaktorbindung (1)
- Kognition (1)
- Kognitive Beeinträchtigung (1)
- Komplement (1)
- Konditionierung (1)
- Konnektivitätsschätzung (1)
- Kopienzahlvariation (1)
- Kraniosynostose (1)
- Krebsforschung (1)
- Kutikula (1)
- Kutikularwachs (1)
- Künstliche Intelligenz (1)
- LPS Biosynthese (1)
- Labeling (1)
- Langerhans cells (1)
- Lasiocarpin (1)
- Latrophilin (1)
- Lebendzellmikroskopie (1)
- Leber-Metabolismus (1)
- Leishmania (1)
- Lenalidomid (1)
- Lernen (1)
- Letalität (1)
- Ligand <Biochemie> (1)
- Lipid Raft (1)
- Lipid Transfer Protein (1)
- Lipide (1)
- Lipolysis (1)
- Lung (1)
- Lunge (1)
- M1 Muscarinic Receptor (1)
- MEK5/ERK5 (1)
- MGMT (1)
- MIZ1 (1)
- MS2-affinity purification and RNA-seq (1)
- Macrophages (1)
- Magnetresonanztomographie (1)
- Makrophage (1)
- Marketing authorisation of pharmaceuticals (1)
- Mauerbiene (1)
- Mechanical deformation (1)
- Mechanismus (1)
- Medium spiny neurons (1)
- Megakaryocyte (1)
- Meninges (1)
- Merkel cell carcinoma (1)
- Merkel cell polyomavirus (1)
- Mesenchymal stem cell (1)
- Mesenchymal stromal cells (1)
- Mesenchymzelle (1)
- Metabolism (1)
- Metabolismus (1)
- Methylierung (1)
- MgrB (1)
- Microglia (1)
- Micronucleus (1)
- Microvesicle (1)
- Mikroglia (1)
- Mitochondria (1)
- Mitochondrien (1)
- Mitochondrium (1)
- Mittelohrimplantat (1)
- Model Organism (1)
- Modellorganismus (1)
- Modellsystem (1)
- Modifizierung (1)
- Monozyt (1)
- Morbus Alzheimer (1)
- Motor learning (1)
- Motorisches Lernen (1)
- Mouse Model (1)
- Mucormykose (1)
- Multiproteinkomplex (1)
- Mundschleimhautzellen (1)
- Muscarinrezeptor (1)
- Mutagenität (1)
- Myb-MuvB complex (1)
- Myeloid (1)
- Myokardinfarkt (1)
- N-Myc (1)
- NK cell (1)
- NK-DC cross-talk (1)
- NRF2 (1)
- NTRK fusions (1)
- Nasenschleimhaut (1)
- Natürliche Killerzelle (1)
- Neisseria gonorrhoeae (1)
- Neuartige Arzneimittel (1)
- Neuralgie (1)
- Neuroanatomie (1)
- Neuroethologie (1)
- Neuroinflammation (1)
- Neuronales visuelles System (1)
- Neuropathie (1)
- Neuropathischer Schmerz (1)
- Neuropeptide (1)
- Neuroprotektivum (1)
- Neuroscience (1)
- Neutrophil (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- Nozizeption (1)
- Nucleotide excision repair (1)
- Nukleotid-Exzisions-Reparatur (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- Obesity (1)
- Opiatrezeptor (1)
- Opioide (1)
- Oxidativer Stress (1)
- Oxygen partial pressure (1)
- P4-ATPase (1)
- PAF1c (1)
- PDE (1)
- PRR (1)
- PVM (1)
- Palbociclib (1)
- Parc National de la Comoé (1)
- Parkinson Krankheit (1)
- Parkinson's disease (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Pathophysiologische Mechanismen (1)
- Pattern-Recognition-Receptors (1)
- Persistence (1)
- Pertussis (1)
- Pflanzenaussterben (1)
- Phasenvariation (1)
- Phenotypic switch (1)
- Phosphodiesterase (1)
- Pilzkörper (1)
- PinT (1)
- Plant cuticle (1)
- Plasmamembran (1)
- Plastizität (1)
- Pneumoviruses (1)
- Pollen (1)
- Positronen-Emissions-Tomografie (1)
- Preclinical studies (1)
- Primäre Ziliendyskinesie (1)
- Primärelement (1)
- Primärzellen (1)
- Progenitor (1)
- Protein purification (1)
- Protein-Protein-Interaktion (1)
- Protein-Protein-Wechselwirkung (1)
- Proteinkinase D (1)
- Proteinmodifizierung (1)
- Präklinische Studien (1)
- Präzisionsmedizin (1)
- Psychotherapie (1)
- Punktmutation (1)
- Pyrrolizidinalkaloide (1)
- QPCR (1)
- Qualitätsindikator (1)
- RNS-Interferenz (1)
- RSV (1)
- Receptor dynamics (1)
- Regenerative Medicine (1)
- Regulation (1)
- Regulatorischer T-Lymphozyt (1)
- Resilienz (1)
- Resistance (1)
- Respiratorisches System (1)
- Rezeptorblocker (1)
- Rezidiv (1)
- Rhizopus arrhizus (1)
- Ribonuclease H2 (1)
- Riboregulation (1)
- Risikofaktoren (1)
- Rossameise (1)
- Röntgenkristallographie (1)
- SLC2A3 (1)
- SMN (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Schimpanse (1)
- Schizosaccharomyces pombe (1)
- Schlaganfall (1)
- Schließzellfunktion (1)
- Secretion (1)
- Sekundäre Inflammation (1)
- Selective extraction (1)
- Senecionin (1)
- Seneciphyllin (1)
- Sequenzwiederholung (1)
- Serotonindefizienz (1)
- Signaltransduktion (1)
- Sleeping Beauty Transposon System (1)
- Small RNA (1)
- Small angle X-ray scattering (1)
- Social action effects (1)
- Sociomotor gaze control (1)
- Soziale Handlungseffekte (1)
- Soziomotorische Blickkontrolle (1)
- SteC (1)
- Sterblichkeit (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Stress (1)
- Striatum (1)
- Strukturbiologie (1)
- Superresolution microscopy (1)
- Survival Motor Neuron (1)
- Synaptic plasticity (1)
- Synchronitätsmessung (1)
- T cell engaging Antibody (1)
- TFIIH (1)
- TH2 Immunantwort (1)
- TLR signaling (1)
- Telomerase (1)
- Thebain (1)
- Therapie (1)
- Therapieresistenz (1)
- Thrombopoiesis (1)
- Tight junction (1)
- Tissue engineering (1)
- Toll-like-Rezeptoren (1)
- TraDIS (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Transkriptomik anlyze (1)
- Transpiration <Pflanzen> (1)
- Transposon (1)
- Treg (1)
- Trend (1)
- Trophic Factors (1)
- Trypanosoma Brucei (1)
- Trypanosoma brucei (1)
- UBE2S (1)
- Ubiquitin-PA (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitin-conjugating enzyme (1)
- Ubiquitinierung (1)
- VW-SCs (1)
- Validierung (1)
- Verhalten (1)
- Verhaltenskontrolle (1)
- Very-long-chain aliphatic (1)
- Vesikelbildung (1)
- Vessel wall (1)
- Virtuelle Realität (1)
- Visuelle Aufmerksamkeit (1)
- Vorläufer (1)
- Water stress (1)
- Wirkstoffdesign (1)
- X-ray crystallography (1)
- X-ray diffraction (1)
- Yeast (1)
- Zellzyklus (1)
- Zink-Finger-Proteine (1)
- aGPCR (1)
- acute graft-versus host disease (1)
- adhesion-GPCR (1)
- adrenal gland (1)
- adrenergic receptor (1)
- adrenocortical carcinoma (1)
- airways (1)
- allogeneic stem cell transplantation (1)
- alloreactive T cells (1)
- antimicrobial (1)
- anxiety disorders (1)
- articular cartilage progenitor cells (1)
- atopic diseases (1)
- attributable fraction (1)
- attributable risk (1)
- autoantibody (1)
- autophagocytose (1)
- autophagy (1)
- bacterial lipid rafts (1)
- behavior (1)
- beta-Arrestin2 (1)
- bicuculline (1)
- binding mode (1)
- biochemistry (1)
- biodistribution (1)
- bioimage analysis (1)
- biokinetics (1)
- biolayerinterferometry (1)
- bioreactor (1)
- blood nerve barrier (1)
- bone marrow (1)
- bumblebee*s (1)
- cancer (1)
- candida (1)
- candida albicans (1)
- cartilage (1)
- chlamydia (1)
- chondrogene Differenzierung (1)
- circadian rhythms (1)
- claudin-12 (1)
- co-culture (1)
- cochlea implant (1)
- cofactorbinding (1)
- compartments (1)
- corneal confocal microscopy (1)
- correlation (1)
- cushing's syndrome (1)
- cytokine release syndrome (1)
- cytoskeleton (1)
- dCIRL (1)
- dSTORM (1)
- developmental differentiation (1)
- diabetic cardiomyopathy (1)
- diagnostics (1)
- diastolic dysfunction (1)
- diet (1)
- disease model (1)
- distance (1)
- distribution (1)
- double-strand break repair (1)
- drug repurposing (1)
- dual RNA-seq (1)
- ecology (1)
- effector protein (1)
- electron microscopy (1)
- eosinophil (1)
- evozierte Potentiale (1)
- exposition training (1)
- expression (1)
- extinction dynamics (1)
- fabry disease (1)
- fear conditioning (1)
- fibromyalgia sydrome (1)
- foraging activity (1)
- foxtapeworm (1)
- fragment screening (1)
- functional membrane microdomains (1)
- functional studies (1)
- fungus (1)
- genotoxicity (1)
- germinative cell (1)
- gezielte Therapie (1)
- glycine receptor autoantibodies (1)
- glycophytes (1)
- guard cells (1)
- habitat (1)
- hematopoiesis (1)
- hippocampus (1)
- homoFRET (1)
- honeybee (1)
- honeybee*s (1)
- huh6 (1)
- iPSC (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- interleukin-5 signaling (1)
- internal dosimetry (1)
- interphase gap (1)
- interpulse interval (1)
- intraoperative Ankopplungseffizienz (1)
- kinase (1)
- labeling techniques (1)
- lasiocarpine (1)
- learning (1)
- lipid rafts (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- mechanistische Modellierung (1)
- melanoma dedifferentiation (1)
- membrane dynamics (1)
- mesenteric lymph node (1)
- metabolic theory of ecology (1)
- microelectrode array (1)
- mouse models (1)
- mucormycosis (1)
- myelin barrier (1)
- neuroethology (1)
- neuromodulation (1)
- neuronal visual system (1)
- neuropeptides (1)
- neutrophil (1)
- nociception (1)
- nutrients (1)
- nutrition (1)
- p97 (1)
- pain (1)
- pathophysiological mechanisms (1)
- peptide (1)
- peptide engineering (1)
- peptide-based interleukin-5 inhibitor (1)
- perception (1)
- phosphorylation (1)
- platelets (1)
- polarized epithelium (1)
- pollen (1)
- polyethism (1)
- polyradiculoneuropathy (1)
- population attributable fraction (1)
- precision medicine (1)
- preclinical PET (1)
- primary ciliary dyskinesia (1)
- primate (1)
- proboscis extension response (1)
- protease (1)
- protein kinase a (1)
- protein regulation and expression (1)
- protein-protein-interaction (1)
- psychosocial resilience (1)
- rapid evolution (1)
- reception (1)
- receptor (1)
- replication (1)
- resilience (1)
- salinen Wachstumsbedingungen (1)
- salt stress (1)
- schnelle Evolution (1)
- self-activation (1)
- senecionine (1)
- seneciphylline (1)
- shRNA (1)
- signalling (1)
- similarity (1)
- skin (1)
- skin biopsy (1)
- small RNA (1)
- small fiber pathology (1)
- small proteins (1)
- somatic resilience (1)
- somatostatin receptor antagonists (1)
- sphingolipids (1)
- ssVEP (1)
- stiff person syndrome (1)
- structural mechanism (1)
- structure analysis (1)
- super-resolution microscopy (1)
- synaptic plasticity (1)
- synaptische Plastizität (1)
- targeted therapy (1)
- tdcs (1)
- temporal information transfer (1)
- test system (1)
- therapy (1)
- time-resolved anisotropy (1)
- tool (1)
- tool-use (1)
- tracheal cytotoxin (1)
- trachomatis (1)
- transcription/replication conflicts (1)
- transcriptome data analysis (1)
- transcriptomic analysis (1)
- transient dynamics (1)
- tumour (1)
- tyrosine kinase (1)
- virulence (1)
- yeast (1)
- zeitlich Informationsübertragung (1)
- zonal Hydrogels (1)
- µ-Opioid Rezeptor (1)
- Ängstliche Depression (1)
Institute
- Graduate School of Life Sciences (124) (remove)
Sonstige beteiligte Institutionen
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- Department of Veterinary Sciences, Experimental Parasitology, Ludwig-Maximilians-Universität München (1)
- Max-Delbrück-Center für molekulare Medizin, Berlin (1)
- Research Center for Infectious Diseases, University of Würzburg (1)
- Spanish National Center for Biotechnology (CNB-CSIC) (1)
- Technische Universität Darmstadt (1)
- University of Applied Sciences Aschaffenburg (1)
- University of Leipzig, Faculty of Life Sciences, Institute for Biology (1)
- Zentrum für Infektionsforschung (ZINF) Würzburg (1)
Neisseria gonorrhoeae (GC) is a human specific pathogenic bacterium. Currently, N. gonorrhoeae developed resistance to virtually all the available antibiotics used for treatment. N. gonorrhoeae starts infection by colonizing the cell surface, followed by invasion of the host cell, intracellular persistence, transcytosis and exit into the subepithelial space. Subepithelial bacteria can reach the bloodstream and disseminate to other tissues causing systemic infections, which leads to serious conditions such as arthritis and pneumonia. A number of studies have well established the host-pathogen interactions during the initial adherence and invasion steps. However, the mechanism of intracellular survival and traversal is poorly understood so far. Hence, identification of novel bacterial virulence factors and host factors involved in the host-pathogen interaction is a crucial step in understanding disease development and uncovering novel therapeutic approaches. Besides, most of the previous studies about N. gonorrhoeae were performed in the conventional cell culture. Although they have provided insights into host-pathogen interactions, much information about the native infection microenvironment, such as cell polarization and barrier function, is still missing.
This work focused on determining the function of novel bacterial virulence factor NGFG_01605 and host factor (FLCN) in gonococcal infection. NGFG_01605 was identified by Tn5 transposon library screening. It is a putative U32 protease. Unlike other proteins in this family, it is not secreted and has no ex vivo protease activity. NGFG_01605 knockout decreases gonococcal survival in the epithelial cell. 3D models based on T84 cell was developed for the bacterial transmigration assay. NGFG_01605 knockout does not affect gonococcal transmigration.
The novel host factor FLCN was identified by shRNA library screening in search for factors that affected gonococcal adherence and/or internalization. We discovered that FLCN did not affect N. gonorrhoeae adherence and invasion but was essential for bacterial survival. Since programmed cell death is a host defence mechanism against intracellular pathogens, we further explored apoptosis and autophagy upon gonococcal infection and determined that FLCN did not affect apoptosis but inhibited autophagy. Moreover, we found that FLCN inhibited the expression of E-cadherin. Knockdown of E- cadherin decreased the autophagy flux and supported N. gonorrhoeae survival. Both non-polarized and polarized cells are present in the cervix, and additionally, E-cadherin represents different polarization properties on these different cells. Therefore, we established 3-D models to better understand the functions of FLCN. We discovered that FLCN was critical for N. gonorrhoeae survival in the 3-D environment as well, but not through inhibiting autophagy. Furthermore, FLCN inhibits the E-cadherin expression and disturbs its polarization in the 3-D models. Since N. gonorrhoeae can cross the epithelial cell barriers through both cell-cell junctions and transcellular migration, we further explored the roles FLCN and E-cadherin played in transmigration. FLCN delayed N. gonorrhoeae transmigration, whereas the knockdown of E-cadherin increased N. gonorrhoeae transmigration.
In summary, we revealed roles of the NGFG_01605 and FLCN-E-cadherin axis play in N. gonorrhoeae infection, particularly in relation to intracellular survival and transmigration. This is also the first study that connects FLCN and human-specific pathogen infection.
Depressionen und Angststörungen sind die beiden häufigsten psychischen Erkrankungen. Für Angststörungen wurde in zahlreichen Untersuchungen die Bedeutung veränderter Muster in den basalen emotional-assoziativen Lernprozessen für die Ätiologie und Aufrechterhaltung der Erkrankung gezeigt. Hierzu zählen eine verstärkte Akquisitionsreaktion auf den konditionierten Stimulus, Defizite in der Inhibition der Furchtreaktion auf den Sicherheit signalisierenden Stimulus, Übergeneralisierung und Beeinträchtigungen in der Extinktion konditionierter Reaktionen.
Aufgrund der hohen Prävalenzen einer Komorbidität mit Depressionen rückte in den letzten Jahren zunehmend die Untersuchung der genannten Prozesse bei Depressionen in den Fokus. Hierfür konnten bisher keine einheitlichen Ergebnisse gezeigt werden.
Weiterhin wird der Subtyp der ängstlichen Depression einerseits mit hohen Prävalenzen beschrieben, andererseits zeigen Untersuchungen eine schlechtere Prognose, stärkere Einschränkungen in der Funktionalität und ein schlechteres Ansprechen auf die Therapie im Vergleich zu depressiven Patienten ohne hohes Ängstlichkeitsniveau.
In dieser Arbeit wurden die Akquisition, Generalisierung und Extinktion in einem differentiellen Konditionierungsparadigma bei schwer depressiven ängstlichen und nicht ängstlich-depressiven Patienten sowie einer gesunden Kontrollgruppe untersucht. Ängstliche und nicht ängstlich-depressive Patienten zeigten ein beeinträchtigtes Sicherheitslernen in der Akquisition und Beeinträchtigungen in der Extinktion der konditionierten Furcht. Es ergaben sich keine Unterschiede hinsichtlich der Stärke der Generalisierung zwischen Patienten und den gesunden Kontrollen und es konnten keine differenzierenden Muster zwischen den ängstlich- und den nicht ängstlich-depressiven Patienten gezeigt werden.
Zusammenfassend weisen die Ergebnisse auf Veränderungen im Furchtlernen bei Patienten mit Depressionen hin. Es konnten keine Belege für unterschiedliche Mechanismen im Furchtlernen von ängstlich- und nicht ängstlich-depressiven Patienten gefunden werden. Unsere Ergebnisse stützen somit die Klassifikation der ängstlichen Depression als Subtyp der Depression. Weiterhin weisen die Ergebnisse der beeinträchtigten Extinktion bei Patienten mit Depressionen darauf hin, dass Expositionselemente, welche bei der Therapie von Angststörungen als Verfahren der Wahl eingesetzt werden, auch bei der Behandlung von Depressionen integriert werden sollten, um so den Therapieerfolg zu verbessern.
In dieser Dissertation wird der MEK5/ERK5- Signalweg als möglicher Angriffspunkt in der zielgerichteten Melanomtherapie identifiziert. Die Adressierung von ERK5 bietet eine Alternative, um einer Resistenzentwicklung gegenüber Inhibitoren des MAPK- Signalwegs entgegenzuwirken. Das maligne Melanom ist ein hochaggressiver Tumor mit steigender Inzidenz. Zunehmende Sonnenstunden im Rahmen des Klimawandels mit erhöhter Belastung der Haut durch UV-Strahlung werden die Problematik des malignen Melanoms für den Menschen in den nächsten Jahren weiter zunehmen lassen.
Die Aktivierung des MEK5/ERK5- Signalwegs scheint eine Reaktion von Tumorzellen auf Therapiestress zu sein. Diese Aktivierung liefert den Melanomzellen einen Überlebensvorteil und verhindert ein langfristiges Therapieansprechen. ERK5 beeinflusst den Zellzyklus von Melanomzellen und ist somit möglicherweise von wichtiger Bedeutung in der Tumorgenese des malignen Melanoms.
Patienten mit NRAS- Mutation profitieren auffallend weniger von einer gezielten MEKi-Therapie als solche mit BRAF Mutation. Für ersteres Patientenkollektiv steht aktuell lediglich die Immuntherapie zur Verfügung, wodurch oft nur ein kurzes, progressionsfreies Intervall erreicht werden kann und die Patienten häufig unter schweren Nebenwirkungen leiden. Grund für die problematische Behandlung könnte das häufige Auftreten einer basalen ERK5- Aktivierung in NRAS- mutierten Melanomen sein. Diese Arbeit liefert eine positive Prognose über den Nutzen einer ERK5- Inhibition als Erweiterung des Therapieschemas. Diese These gilt auch für Melanompatienten mit einer BRAF- Mutation. Patienten, die an einem malignen Melanom erkrankt sind, weisen zu 80% eine Mutation in einem dieser beschriebenen Onkogene auf. Die Arbeit lässt darauf schließen, dass eine ERK5- Inhibition in der Therapie von beiden Gruppen erfolgreich sein könnte und somit das Leben nahezu aller Melanompatienten betrifft.
The human pathogen Aspergillus (A.) fumigatus is a fungal mold that can cause severe infections in immunocompromised hosts. Pathogen recognition and immune cell cross-talk are essential for clearing fungal infections efficiently. Immune cell interactions in particular may enhance individual cell activation and cytotoxicity towards invading pathogens.
This study analyzed the reciprocal cell activation of natural killer (NK) cells and monocyte-derived dendritic cells (moDCs) after stimulation with A. fumigatus cell wall fractions and whole-cell lysates. Furthermore, the impact of the on moDCs expressed fungal receptors Dectin-1 and TLR-2 on NK cell activation was analyzed. Stimulation of moDCs with ligands for Dectin-1 and TLR-2 and transfer of soluble factors on autologous NK cells showed that moDCs could induce NK cell activation solely by secreting factors. In summary, both cell types could induce reciprocal cell activation if the stimulated cell type recognized fungal morphologies and ligands. However, moDCs displayed a broader set of A. fumigatus receptors and, therefore, could induce NK cell activation when those were not activated by the stimulus directly.
Consequently, new fungal receptors should be identified on NK cells. The NK cell characterization marker CD56 was reduced detected in flow cytometry after fungal co-culture. Notably, this decreased detection was not associated with NK cell apoptosis, protein degradation, internalization, or secretion of CD56 molecules. CD56 was shown to tightly attach to hyphal structures, followed by its concentration at the NK-A. fumigatus interaction site. Actin polymerization was necessary for CD56 relocalization, as pre-treatment of NK cells with actin-inhibitory reagents abolished CD56 binding to the fungus. Blocking of CD56 suppressed fungal mediated NK cell activation and secretion of the immune-recruiting chemokines MIP-1α, MIP-1β, and RANTES, concluding that CD56 is functionally involved in fungal recognition by NK cells.
CD56 binding to fungal hyphae was inhibited in NK cells obtained from patients during immune-suppressing therapy after allogeneic stem cell transplantation (alloSCT). Additionally, reduced binding of CD56 correlated with decreased actin polymerization of reconstituting NK cells challenged with the fungus. The immune-suppressing therapy with corticosteroids negatively influenced the secretion of MIP-1α, MIP-1β, and RANTES in NK cells after fungal stimulation ex vivo. Similar results were obtained when NK cells from healthy donors were treated with corticosteroids prior to fungal co-culture. Thus, corticosteroids were identified to have detrimental effects on NK cell function during infection with A. fumigatus.
Adrenal Cushing’s Syndrome (CS) is a rare but life-threatening disease and therefore it is of great importance to understand the pathogenesis leading to adrenal CS. It is well accepted that Protein Kinase A (PKA) signalling mediates steroid secretion in adrenocortical cells. PKA is an inactive heterotetramer, consisting of two catalytic and two regulatory subunits. Upon cAMP binding to the regulatory subunits, the catalytic subunits are released and are able to phosphorylate their target proteins. Recently, activating somatic mutations affecting the catalytic subunit a of PKA have been identified in a sub-population of cortisol-producing adenomas (CPAs) associated with overt CS. Interestingly, the PKA regulatory subunit IIb has long been known to have significantly lower protein levels in a sub-group of CPAs compared to other adrenocortical tumours. Yet, it is unknown, why these CPAs lack the regulatory subunit IIb, neither are any functional consequences nor are the underlying regulation mechanisms leading to reduced RIIb levels known. The results obtained in this thesis show a clear connection between Ca mutations and reduced RIIb protein levels in CPAs but not in other adrenocortical tumours. Furthermore, a specific pattern of PKA subunit expression in the different zones of the normal adrenal gland is demonstrated. In addition, a Ca L206R mutation-mediated degradation of RIIb was observed in adrenocortical cells in vitro. RIIb degradation was found to be mediated by caspases and by performing mutagenesis experiments of the regulatory subunits IIb and Ia, S114 phosphorylation of RIIb was identified to make RIIb susceptible for degradation. LC-MS/MS revealed RIIb interaction partners to differ in the presence of either Ca WT and Ca L206R. These newly identified interaction partners are possibly involved in targeting RIIb to subcellular compartments or bringing it into spatial proximity of degrading enzymes. Furthermore, reducing RIIb protein levels in an in vitro system were shown to correlate with increased cortisol secretion also in the absence of PRKACA mutations. The inhibiting role of RIIb in cortisol secretion demonstrates a new function of this regulatory PKA subunit, improving the understanding of the complex regulation of PKA as key regulator in many cells.
Cellular membranes form a boundary to shield the inside of a cell from the outside. This is of special importance for bacteria, unicellular organisms whose membranes are in direct contact with the environment. The membrane needs to allow the reception of information about beneficial and harmful environmental conditions for the cell to evoke an appropriate response. Information gathering is mediated by proteins that need to be correctly organized in the membrane to be able to transmit information. Several principles of membrane organization are known that show a heterogeneous distribution of membrane lipids and proteins. One of them is functional membrane microdomains (FMM) which are platforms with a distinct lipid and protein composition. FMM move within the membrane and their integrity is important for several cellular processes like signal transduction, membrane trafficking and cellular differentiation. FMM harbor the marker proteins flotillins which are scaffolding proteins that act as chaperones in tethering protein cargo to FMM. This enhances the efficiency of cargo protein oligomerization or complex formation which in turn is important for their functionality. The bacterium Bacillus subtilis contains two flotillin proteins, FloA and FloT. They form different FMM assemblies which are structurally similar, but differ in the protein cargo and thus in the specific function.
In this work, the mobility of FloA and FloT assemblies in the membrane was dissected using live-cell fluorescence microscopy techniques coupled to genetic, biochemical and molecular biological methods. A characteristic mobility pattern was observed which revealed that the mobility of both flotillins was spatially restricted. Restrictions were bigger for FloT resulting in a decreased diffusion coefficient compared to FloA. Flotillin mobility depends on the interplay of several factors. Firstly, the intrinsic properties of flotillins determine the binding of different protein interaction partners. These proteins directly affect the mobility of flotillins. Additionally, binding of interaction partners determines the assembly size of FloA and FloT. This indirectly affects the mobility, as the endo-cytoskeleton spatially restricts flotillin mobility in a size-dependent manner. Furthermore, the extracellular cell wall plays a dual role in flotillin mobility: its synthesis stimulates flotillin mobility, while at the same time its presence restricts flotillin mobility. As the intracellular flotillins do not have spatial access to the exo-cytoskeleton, this connection is likely mediated indirectly by their cell wall-associated protein interaction partners. Together the exo- and the endo-cytoskeleton restrict the mobility of FloA and FloT.
Similar structural restrictions of flotillin mobility have been reported for plant cells as well, where the actin cytoskeleton and the cell wall restrict flotillin mobility. These similarities between eukaryotic and prokaryotic cells indicate that the restriction of flotillin mobility might be a conserved mechanism.
Investigations into the Pathogenic Antibody-Antigen-Interference of Glycine Receptor Autoantibodies
(2021)
Anti-glycine receptor (GlyR) autoantibodies belong to the novel group of autoantibodies that target neuronal cell-surface antigens (NCS), which are accompanied with various neurologic and neuropsychiatric conditions. The inhibitory ionotropic GlyR is one of the major inhibitory neurotransmitter receptors and therefore involved in maintaining homeostasis of neuronal excitation levels at brain stem and spinal cord. Anti-GlyR autoantibodies are associated with progressive encephalomyelitis with rigidity and myoclonus or stiff person syndrome. These neuromotor disorders are characterized by exaggerated startle, muscle stiffness, and painful spasms, leading to immobility and fatal outcome in some cases. It was hypothesized that imbalance of motoneuronal inhibition by functional impairment of GlyR and receptor internalization are direct consequences of antibody-antigen interference. Here, serum samples of four patients were tested for anti-GlyR autoantibodies and were used for the analysis of the functional impact on the electrophysiological properties of recombinant GlyRs, transiently expressed in HEK293 cells. Furthermore, the recognition pattern of anti- GlyR autoantibodies to human, zebrafish and chimeric GlyRα1 located the epitope to the far N-terminal region. The pathogenicity of anti-GlyR autoantibodies and thereby the autoimmunologic etiology of the disease was confirmed by passive transfer of patient serum to zebrafish (Danio rerio) larvae, that yielded an abnormal escape response – a brain stem reflex that corresponds to the exaggerated startle of afflicted patients. The phenotype was accompanied by profound reduction of GlyR clusters in spinal cord cryosections of treated zebrafish larvae. Together, these novel insights into the pathogenicity of GlyR autoantibodies confirm the concept of a novel neurologic autoimmune disease and might contribute to the development of innovative therapeutic strategies.
The past decades have witnessed the development of new pharmaceutical compounds that modulate receptor function by targeting allosteric sites. Allosteric sites are, by definition, domains topographically distinct from the orthosteric binding pocket where the natural ligand binds. Exploring the possibilities of linking orthosteric and allosteric pharmacophores in one compound to yield ‘bitopic’ compounds is a strategy derived from the “message-address” concept by Schwyzer , first applied to GPCRs by Portoghese et al. This concept explicitly underlines the orthosteric/allosteric combination, in opposite to the more general umbrella term bivalent. The broad possibilities of bitopic ligands in the pharmaceutical field are under continuous study. Bitopic compounds are promising pharmaceutical tools for taking advantage of the allosteric binding to achieve subtype selectivity while preserving high affinity at the receptor. The development of bitopic ligands, based on the idea of combining high affinity (via orthosteric sites) with high selectivity (via allosteric sites), have led to the development of highly selective bivalent ligands for GPCRs , such as for the opioid receptors , muscarinic acetylcholine receptors (mAChRs), serotonin receptors, cannabinoid receptors, and gonadotropin-releasing hormone receptors. This concept has even been extended to other receptors, for examples nicotinic receptors and other proteins, such as acetylcholinesterases and the tyrosine kinase receptors TrkA and TrkC. The reasons to pursue a bitopic ligand approach are various. An improved affinity for the target GPCR and/or an improved selectivity either at the level of receptor subtype, or at the level of signaling pathway. Another advantage of bitopic ligands over purely allosteric ligands is that the former rely on the appropriate presence of endogenous agonist tone to mediate their effects, whereas a bitopic ligand would engage the orthosteric site irrespective of the presence or absence of endogenous tone. By way of introduction to the hybrid approach, a review of the concept of hybrids compounds targeting the cholinergic system is presented in section A of this thesis. Recent updates in hybrid molecule design as a strategy for selectively addressing multiple target proteins involved in Alzheimer's disease (AD) is here reported . This represents the potential and the growing interest in hybrid compound as pharmacological tools to achieve receptor subtype selectivity and/or, to study the overall functional activity of the receptor. Until now, muscarinic acetylcholine receptors (mAChRs) have proved to be a particularly fruitful receptor model for the development and characterization of bitopic ligands. In this thesis, several examples of new muscarinic bitopic approach are reported in the results section. A study of bipharmacophoric ligands composed of the muscarinic positive allosteric modulators (BQCAderived compounds) linked with chain of various lengths to different orthosteric building blocks is reported in the result part 1. Synthesis and examination of the potential pharmacological characteristic of Oxotremorine-BQCAd compounds and Xanomeline-BQCAd hybrid derivatives are described in results parts 2 and 4, respectively. Moreover, the bitopic concept has even been extended to other proteins, such as acetylcholinesterase. In the result part 5 an overview of the new Tacrine-Xanomeline hybrids aiming to improve the inhibitory potency of the acetylcholinesterase and simultaneously to increase the cholinergic tone, via the xanomelinic portion acting on the M1 receptor is given. A new trivalent approach is presented for the first time to deepen the study of the M1 muscarinic receptor in the result part 6. Moreover, the synthesis of a new series of iperoxo-derived alkane, bis(ammonio)alkane-type and rigidified chain ligands is given in the result part 7 together with some prospects for further research.
Chlamydia trachomatis, an obligate intracellular human pathogen, is the world’s leading cause of infection related blindness and the most common, bacterial sexually transmitted disease. In order to establish an optimal replicative niche, the pathogen extensively interferes with the physiology of the host cell. Chlamydia switches in its complex developmental cycle between the infectious non-replicative elementary bodies (EBs) and the non-infectious replicative reticulate bodies (RBs). The transformation to RBs, shortly after entering a host cell, is a crucial process in infection to start chlamydial replication. Currently it is unknown how the transition from EBs to RBs is initiated. In this thesis, we could show that, in an axenic media approach, L glutamine uptake by the pathogen is crucial to initiate the EB to RB transition. L-glutamine is converted to amino acids which are used by the bacteria to synthesize peptidoglycan. Peptidoglycan inturn is believed to function in separating dividing Chlamydia. The glutamine metabolism is reprogrammed in infected cells in a c-Myc-dependent manner, in order to accomplish the increased requirement for L-glutamine. Upon a chlamydial infection, the proto-oncogene c-Myc gets upregulated to promote host cell glutaminolysis via glutaminase GLS1 and the L-glutamine transporter SLC1A5/ASCT2. Interference with this metabolic reprogramming leads to limited growth of C. trachomatis. Besides the active infection, Chlamydia can persist over a long period of time within the host cell whereby chronic and recurrent infections establish. C. trachomatis acquire a persistent state during an immune attack in response to elevated interferon-γ (IFN-γ) levels. It has been shown that IFN-γ activates the catabolic depletion of L-tryptophan via indoleamine 2,3-dioxygenase (IDO), resulting in the formation of non-infectious atypical chlamydial forms. In this thesis, we could show that IFN-γ depletes the key metabolic regulator c-Myc, which has been demonstrated to be a prerequisite for chlamydial development and growth, in a STAT1-dependent manner. Moreover, metabolic analyses revealed that the pathogen de routs the host cell TCA cycle to enrich pyrimidine biosynthesis. Supplementing pyrimidines or a-ketoglutarate helps the bacteria to partially overcome the persistent state. Together, the results indicate a central role of c-Myc induced host glutamine metabolism reprogramming and L-glutamine for the development of C. trachomatis, which may provide a basis for anti-infectious strategies. Furthermore, they challenge the longstanding hypothesis of L-tryptophan shortage as the sole reason for IFN-γ induced persistence and suggest a pivotal role of c-Myc in the control of the C. trachomatis dormancy.
Small proteins, often defined as shorter than 50 amino acids, have been implicated
in fundamental cellular processes. Despite this, they have been largely understudied throughout all domains of life, since their size often makes their identification and characterization challenging.
This work addressed the knowledge gap surrounding small proteins with a focus
on the model bacterial pathogen Salmonella Typhimurium. In a first step,
new small proteins were identified with a combination of computational and experimental approaches. Infection-relevant datasets were then investigated with
the updated Salmonella annotation to prioritize promising candidates involved in virulence.
To implement the annotation of new small proteins, predictions from the algorithm
sPepFinder were merged with those derived from Ribo-seq. These were added to the Salmonella annotation and used to (re)analyse different datasets. Information
regarding expression during infection (dual RNA-seq) and requirement for virulence (TraDIS) was collected for each given coding sequence. In parallel,
Grad-seq data were mined to identify small proteins engaged in intermolecular
interactions.
The combination of dual RNA-seq and TraDIS lead to the identification of small
proteins with features of virulence factors, namely high intracellular induction
and a virulence phenotype upon transposon insertion. As a proof of principle of
the power of this approach in highlighting high confidence candidates, two small
proteins were characterized in the context of Salmonella infection.
MgrB, a known regulator of the PhoPQ two-component system, was shown to be essential for the infection of epithelial cells and macrophages, possibly via its stabilizing effect on flagella or by interacting with other sensor kinases of twocomponent
systems. YjiS, so far uncharacterized in Salmonella, had an opposite role in infection, with its deletion rendering Salmonella hypervirulent. The mechanism underlying this, though still obscure, likely relies on the interaction with
inner-membrane proteins.
Overall, this work provides a global description of Salmonella small proteins in
the context of infection with a combinatorial approach that expedites the identification
of interesting candidates. Different high-throughput datasets available for
a broad range of organisms can be analysed in a similar manner with a focus on small proteins. This will lead to the identification of key factors in the regulation
of various processes, thus for example providing targets for the treatment of bacterial
infections or, in the case of commensal bacteria, for the modulation of the microbiota composition.